ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
(Share code: APN)
(ISIN Code: ZAE000023586)
("Aspen")
Dealing in shares by directors
In terms of Rules 3.72 - 3.75 of the Listings Requirements of the JSE
Securities Exchange South Africa ("the JSE"), Aspen announces the following
dealings in Aspen shares by certain of its directors:
On 2 November 1998, prior to the acquisition by Aspen of the pharmaceutical
businesses of South African Druggists Limited, which became effective on 28
February 1999, SB Saad ("Saad") and MG Attridge ("Attridge") granted call
options ("the call options") over 7 225 000 and 2 550 000 Aspen shares,
respectively, at 300 cents per share, to certain third parties ("the option
holders") exercisable on or before 31 December 2003 subject to certain
conditions. On satisfaction of these conditions the option holders exercised
the call options and, accordingly, on 31 January 2002, the option holders
acquired the Aspen shares referred to above from Saad and Attridge.
Woodmead
31 January 2002
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
